2019 Journal Club - Webinar #2
Share |

Journal Club Webinar #2

Monday, September 23rd, 2019 | 11:00am - 12:00pm

Speaker Information/Program Description: The New Practitioner Executive Committee will be hosting online journal clubs to help you stay up-to-date with recent literature. Learn about two recent studies published in the New England Journal of Medicine from two new practitioner members.

Pioneer 6 - Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

View Article: Download PDF
Description:
All new diabetic medications must run safety studies with their new products to ensure that their drugs do not cause negative cardiac outcomes. Recently, some of these studies not only prove they do not worsen cardiovascular outcomes, but also indicate they may help to reduce the risk of such cardiovascular events. Pioneer 6 explores a novel oral GLP-1 analog, semaglutide, and how it affects cardiovascular outcomes in diabetics. 

Objectives:

  1. Be able to explain how the novel oral semaglutide affects patients’ cardiovascular outcomes

Speaker: John Andraos, PharmD
                Ambulatory Care Resident | Cedars-Sinai Medical Care Foundation 


Venetoclax and Obinutuzumab in Chronic Lymphocytic Leukemia (CLL14)

View Article: Download PDF
Description:
Chronic lymphocytic leukemia (CLL) is a cancer that commonly affects older adults with comorbidities. CLL14 is a trial that investigates the efficacy and safety of a set-duration combination regimen venetoclax-obintuzumab vs. chlorambucil-obinutuzumab in untreated CLL patients with coexisting conditions. This presentation will analyze this trial and describe venetoclax-obinutuzumab's role in therapy for CLL. 

Objectives:

  1. Compare the outcomes related to the use of venetoclax-obinutuzumab vs. chlorambucil-obinutuzumab for the initial treatment of chronic lymphocytic leukemia (CLL) in adults.
  2. Describe venetoclax-obinutuzumab's place in therapy for CLL.

Speaker: Thao Nguyen, PharmD
                PGY2 Oncology Pharmacy Resident |Kaiser Permanente San Diego

 

Webinar Information
ACPE Information: 
0126-0000-19-160-L01-P & 0126-0000-19-161-L01-P
Target Audience:
 Pharmacists, New Practitioners
Activity Type: Knowledge-based
Event: Online Webinar
Registration: https://zoom.us/webinar/register/WN_-Pv8zkCiSeubG2JstNPklw
Cost: $0 for Members and Non-members
Release Date: 9/22/2019
Expiration Date: 11/6/2019
Each presentation is accredited for 0.5 hours (0.05 CEUs) of CPE credit.
Credit must be claimed no later than: 11/5/2019

 


Accreditation for this program is provided by the California Society of Health-System Pharmacists (CSHP). CSHP is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. To receive credit, go to www.cshp.org/cpe and follow the directions carefully. A  NABP e-Profile ID is required to claim credit. CSHP is not responsible for credit report failure as a result of incorrect NABP information. Please contact education@cshp.org or 916.447.1033 with questions.

 

Journal Club 2019 - Past Webinars/Schedule

Item Name Posted By Date Posted
Webinar #1 - May 15th, 2019 Link Administration 9/16/2019

Contacts

California Society of Health-System Pharmacists
1314 H Street, Suite 200
Sacramento, CA 95814
Office: (916) 447-1033
Fax: (916) 447-2396
Email: info@cshp.org
Hours: M-F 8:00am – 5:00pm

Connect